2009
DOI: 10.1007/s10585-009-9287-2
|View full text |Cite
|
Sign up to set email alerts
|

MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection

Abstract: MicroRNAs (miRs) are a novel class of RNAs with important roles in regulating gene expression. To identify miRs controlling prostate tumor progression, we utilized unique human prostate sublines derived from the parental P69 cell line, which differ in their tumorigenic properties in vivo. Grown embedded in laminin-rich extracellular matrix (lrECM) gels these genetically-related sublines displayed drastically different morphologies correlating with their behaviour in vivo. The non-tumorigenic P69 subline grew a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
56
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 56 publications
(58 citation statements)
references
References 56 publications
2
56
0
Order By: Relevance
“…In support of this hypothesis, mir-30e and miR-30e* produced from one pre-miRNA have been shown to target two sets of entirely different genes (33). Zhang et al found miR-30e and miR-30e* to be significantly upregulated in the brain of B6C3F1 mice fed diets supplemented with hexahydro-1,3,5-trinitro-1,3,5 -triazine (RDX), a potential human carcinogen, causing neurotoxicity, immunotoxicity, and an increased likelihood of cancer development (35). Thus, it would be of great interest to further determine whether targeting the whole stem loop of the miR-30e/30e* pre-miRNA can be a potential strategy for inhibition of multiple aggressive features of gliomas.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In support of this hypothesis, mir-30e and miR-30e* produced from one pre-miRNA have been shown to target two sets of entirely different genes (33). Zhang et al found miR-30e and miR-30e* to be significantly upregulated in the brain of B6C3F1 mice fed diets supplemented with hexahydro-1,3,5-trinitro-1,3,5 -triazine (RDX), a potential human carcinogen, causing neurotoxicity, immunotoxicity, and an increased likelihood of cancer development (35). Thus, it would be of great interest to further determine whether targeting the whole stem loop of the miR-30e/30e* pre-miRNA can be a potential strategy for inhibition of multiple aggressive features of gliomas.…”
Section: Discussionmentioning
confidence: 99%
“…miRNAs have been demonstrated to play important roles in the initiation and progression of human cancers and therefore may represent promising targets for anticancer therapies (27)(28)(29)(30)(31)(32). During the miRNA maturation process, two functional complementary short RNA molecules, designated miRNA and miRNA*, are formed (33)(34)(35)(36). Here, using the human glioma as a model, we report a miRNA*-mediated mechanism that disrupts the NF-κB/IκB negative feedback loop and results in constitutive activation of NF-κB, leading to the aggressiveness of glioma.…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, Takeshita et al 46 reported that systemic delivery of miR-16 by atelocollagen inhibits the growth of metastatic prostate cancer in bone of nude mice, and may potentially be used for the treatment of metastatic prostate cancer. Zhang et al 47 observed that miR-17-3p regulates the expression of vimentin and altered expression of miR-17-3p decreases the tumorigenic behavior and reduces tumor size in nude mice. Saini et al 51 also noted that relative miR-203 expression is lower in prostate cancer cell lines derived from bone metastasis, and over-expression of miR-203 has a negative effect on the development of metastases in nude mice.…”
Section: Mirnas As Biomarkers In Prostate Cancer Pathogenesismentioning
confidence: 99%
“…miR-17-3p has 22 nucleotides, and there are several studies about its functions (45). A study by Suárez et al (30) has shown that ICAM-1 is a target of TNF-induced miR-17-3p in endothelial cells.…”
Section: Discussionmentioning
confidence: 99%